ANL 15.53 Increased By ▲ 15.53 (0%)
ASC 13.14 Increased By ▲ 13.14 (0%)
ASL 17.85 Increased By ▲ 17.85 (0%)
BOP 8.33 Increased By ▲ 8.33 (0%)
BYCO 7.35 Increased By ▲ 7.35 (0%)
FCCL 17.52 Increased By ▲ 17.52 (0%)
FFBL 22.53 Increased By ▲ 22.53 (0%)
FFL 12.56 Increased By ▲ 12.56 (0%)
FNEL 7.50 Increased By ▲ 7.50 (0%)
GGGL 17.21 Increased By ▲ 17.21 (0%)
GGL 30.50 Increased By ▲ 0.50 (1.67%)
HUMNL 6.95 Increased By ▲ 0.30 (4.51%)
JSCL 19.40 Increased By ▲ 19.40 (0%)
KAPCO 27.31 Increased By ▲ 27.31 (0%)
KEL 3.36 Increased By ▲ 3.36 (0%)
MDTL 2.20 Increased By ▲ 2.20 (0%)
MLCF 35.00 Increased By ▲ 0.75 (2.19%)
NETSOL 104.99 Increased By ▲ 104.99 (0%)
PACE 4.12 Increased By ▲ 4.12 (0%)
PAEL 26.60 Increased By ▲ 26.60 (0%)
PIBTL 8.08 Increased By ▲ 8.08 (0%)
POWER 7.25 Increased By ▲ 7.25 (0%)
PRL 16.10 Increased By ▲ 0.30 (1.9%)
PTC 9.06 Increased By ▲ 9.06 (0%)
SILK 1.42 Increased By ▲ 1.42 (0%)
SNGP 39.74 Increased By ▲ 39.74 (0%)
TELE 16.61 Increased By ▲ 16.61 (0%)
TRG 123.46 Increased By ▲ 123.46 (0%)
UNITY 29.43 Increased By ▲ 29.43 (0%)
WTL 2.29 Increased By ▲ 2.29 (0%)
BR100 4,760 Increased By ▲ 116.8 (2.52%)
BR30 20,622 Increased By ▲ 327.01 (1.61%)
KSE100 45,851 Increased By ▲ 546.91 (1.21%)
KSE30 17,940 Increased By ▲ 231.5 (1.31%)
Business & Finance

EU says discussions will continue with AstraZeneca to get more vaccines in Q1

  • The Commission president Ursula von der Leyen said AstraZeneca had raised its target of supplies to the EU to 40 million doses from 31 million until the end of March, after a large cut last week.
  • Its original commitment was of at least 80 million doses, and possibly up to 120 million in the first quarter.
01 Feb 2021

BRUSSELS: The European Commission will continue discussions with AstraZeneca with the purpose of receiving more doses of its COVID-19 vaccine than the company has so far pledged in the first quarter of the year, a spokesman said on Monday.

On Sunday, the Commission president Ursula von der Leyen said AstraZeneca had raised its target of supplies to the EU to 40 million doses from 31 million until the end of March, after a large cut last week.

Its original commitment was of at least 80 million doses, and possibly up to 120 million in the first quarter, EU sources told Reuters last week.

The offer by AstraZeneca was an improvement but "it is definitely not the amount which we expect to receive until the end of the first quarter, so of course discussions will continue," the spokesman told a news conference.

Comments

Comments are closed.